Building upon a tradition of excellence. The NCTN at IUSCCC
About This Grant
Abstract Indiana University Melvin and Bren Simon Comprehensive Cancer Center (IUSCCC) brings mulƟdisciplinary research teams with experƟse in translaƟonal sciences along with streamlined resources, efficient services, and an insƟtuƟonal environment that fosters innovaƟve clinical and translaƟonal research to the NaƟonal Clinical Trial Network (NCTN). IUSCCC invesƟgators have led trials that defined the standard of care in thymoma, testes, pancreas, and breast cancer. We are commiƩed to leading and supporƟng the next generaƟon of translaƟonal trials within the NCTN. As a Lead Academic ParƟcipaƟng Site we will pursue six specific aims: 1)Integrate genomics, pharmacogenomics, and other molecular assays with tradiƟonal histopathology and imaging to individualize therapy, 2)Lead clinical and translaƟonal research in key rare tumors, 3)Share immunology experƟse across the NCTN, 4)Ensure that all paƟents benefit from the NCTN, 5)Lend experƟse to NCTN operaƟonal efficiency iniƟaƟves, and 6)Mentor junior faculty members to lead the next generaƟon of translaƟonal clinical trials. To accomplish those specific aims, we employ a coordinated clinical trial infrastructure that is efficient and cost-effecƟve, meeƟng the needs of invesƟgators from iniƟal study concept through compleƟon and reporƟng. Overall leadership of the NCTN at IUSCCC is vested in Dr. Kathy Miller, a seasoned invesƟgator who has led three naƟonal trials coordinated by ECOG-ACRIN and recently completed two terms as Co-Chair of the NCI Breast Cancer Steering CommiƩee. Dr. Miller enjoys widespread insƟtuƟonal and mulƟdisciplinary support and is fully empowered to leverage resources to increase accrual and movement of IUSCCC translaƟonal science forward to the NCTN. She is joined in leadership by key invesƟgators in Gynecologic and RadiaƟon Oncology. In this applicaƟon IU will be joined by one affiliate, the Richard A Roudebush VA Medical Center. IUSCCC contributed ~50 paƟents over the most recent 5- year period (3/2019-9/2024) to NCTN; accrual has increased since the pandemic-decline with 79 paƟents enrolled in 2024. Accrual has been evenly split between trials sponsored by ECOG-ACRIN and NRG, together accounƟng for ~80% of our total. In addiƟon, IUSCCC invesƟgators have held key leadership roles within ECOG and the NRG and have made key scienƟfic contribuƟons employing biologic specimens banked as part of cooperaƟve group trials.
Grant Summary
Building upon a tradition of excellence. The NCTN at IUSCCC is a NCI - National Cancer Institute grant providing up to $367K for university, nonprofit, healthcare org. Applications are due 2032-02-29 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $367K
2032-02-29
- 1Confirm your organization is eligible for Building upon a tradition of excellence. The NCTN at IUSCCC from NCI - National Cancer Institute, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NCI - National Cancer Institute before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NCI - National Cancer Institute's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Building upon a tradition of excellence. The NCTN at IUSCCC: Frequently Asked Questions
Who is eligible for the Building upon a tradition of excellence. The NCTN at IUSCCC?
Building upon a tradition of excellence. The NCTN at IUSCCC is offered by NCI - National Cancer Institute and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Building upon a tradition of excellence. The NCTN at IUSCCC provide?
Building upon a tradition of excellence. The NCTN at IUSCCC provides up to $367K per award from NCI - National Cancer Institute. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Building upon a tradition of excellence. The NCTN at IUSCCC deadline?
Applications for Building upon a tradition of excellence. The NCTN at IUSCCC are due 2032-02-29 (open). Because deadlines can change, verify the date with the funder, NCI - National Cancer Institute, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Building upon a tradition of excellence. The NCTN at IUSCCC?
To apply for Building upon a tradition of excellence. The NCTN at IUSCCC, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NCI - National Cancer Institute.